Cargando…
Radiomics Study for Predicting the Expression of PD-L1 and Tumor Mutation Burden in Non-Small Cell Lung Cancer Based on CT Images and Clinicopathological Features
BACKGROUND: The present study compared the predictive performance of pretreatment computed tomography (CT)-based radiomics signatures and clinicopathological and CT morphological factors for ligand programmed death-ligand 1 (PD-L1) expression level and tumor mutation burden (TMB) status and further...
Autores principales: | Wen, Qiang, Yang, Zhe, Dai, Honghai, Feng, Alei, Li, Qiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8377473/ https://www.ncbi.nlm.nih.gov/pubmed/34422625 http://dx.doi.org/10.3389/fonc.2021.620246 |
Ejemplares similares
-
Pretreatment CT-Based Radiomics Signature as a Potential Imaging Biomarker for Predicting the Expression of PD-L1 and CD8+TILs in ESCC
por: Wen, Qiang, et al.
Publicado: (2020) -
Evaluation of PD-L1 Expression Level in Patients With Non-Small Cell Lung Cancer by (18)F-FDG PET/CT Radiomics and Clinicopathological Characteristics
por: Li, Jihui, et al.
Publicado: (2021) -
Clinicopathologic Features and Prognosis of BRAF Mutated Colorectal Cancer Patients
por: Guan, Wen-Long, et al.
Publicado: (2020) -
Correlation between gene mutation status and clinicopathologic features in early multiple primary lung cancer
por: Teng, Fei, et al.
Publicado: (2023) -
CT Radiomics in Predicting EGFR Mutation in Non-small Cell Lung Cancer: A Single Institutional Study
por: Wu, Shanshan, et al.
Publicado: (2020)